Your browser doesn't support javascript.
loading
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Ariza-Heredia, Ella J; Winston, Drew J; Rowley, Scott D; Mullane, Kathleen; Chandrasekar, Pranatharthi; Hari, Parameswaran; Avery, Robin K; Peggs, Karl S; Kumar, Deepali; Nath, Rajneesh; Ljungman, Per; Mossad, Sherif B; El Haddad, Lynn; Shah, Dimpy P; Jiang, Ying; Khawaja, Fareed; Dadwal, Sanjeet; Blanchard, Ted; Chemaly, Roy F.
Afiliação
  • Ariza-Heredia EJ; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Winston DJ; Ronald Reagan UCLA Medical Center, Los Angeles, California, USA.
  • Rowley SD; Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Mullane K; Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Chandrasekar P; Division of Infectious Diseases, Department of Medicine, Karmanos Cancer Center, Wayne State University, Detroit, Michigan, USA.
  • Hari P; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Avery RK; Division of Infectious Diseases (Transplant Oncology), Johns Hopkins University, Baltimore, Maryland, USA.
  • Peggs KS; Department of Haematology, University College London Cancer Institute and University College London Hospitals National Health Service Foundation Trust, London, UK.
  • Kumar D; Transplant Infectious Diseases, University Health Network, Toronto, Canada.
  • Nath R; Bone Marrow Transplant, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge, and Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Mossad SB; Department of Infectious Diseases, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • El Haddad L; Department of Medicine, University of Florida, Gainesville, Florida, USA.
  • Shah DP; Department of Population Health Sciences, Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, Texas, USA.
  • Jiang Y; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Khawaja F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dadwal S; Division of Infectious Diseases, City of Hope, Duarte, California, USA.
  • Blanchard T; Oxford Immunotec USA, Marlborough, Massachusetts, USA.
  • Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Open Forum Infect Dis ; 10(8): ofad386, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37636519
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos